Crossmark

blaVIM- and blaOXA-mediated carbapenem resistance among Acinetobacter baumannii and Pseudomonas aeruginosa isolates from the Mulago hospital intensive care unit in Kampala, Uganda

Crossref DOI link: https://doi.org/10.1186/s12879-019-4510-5

Published Online: 2019-10-16

Published Print: 2019-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Aruhomukama, Dickson

Najjuka, Christine F.

Kajumbula, Henry

Okee, Moses

Mboowa, Gerald

Sserwadda, Ivan

Mayanja, Richard

Joloba, Moses L.

Kateete, David P. http://orcid.org/0000-0001-8075-3069
License Information

Text and Data Mining valid from 2019-10-16

Version of Record valid from 2019-10-16
More Information

Article History

Received: 14 February 2019

Accepted: 24 September 2019

First Online: 16 October 2019

Ethics approval and consent to participate

: Ethical approvals were obtained from the Higher Degrees Research and Ethics Committee of the School of Biomedical Sciences (approval number: SBS-509), Makerere University. The Ethics Committee waived the requirement for informed consent as the investigated isolates were obtained from clinical specimens referred to the diagnostic laboratory as part of routine care.

: Not applicable.

: David Kateete is an editorial board member for BMC Infectious Diseases.

Document is current

Any future updates will be listed below